Jane Doe and Menopausal Transition

December 22, 2023by Dr. S. F. Czar0

Jane Doe and Menopausal Transition

Background Information

( Menopausal Transition )

Patient Name: Jane Doe

Age: 52 years

Medical History: Hypertension managed with medication, no history of diabetes or cardiovascular diseases

Family History: Mother had osteoporosis; father had a history of heart disease

Current Symptoms: Frequent hot flashes, night sweats, mood swings, and recent increase in blood pressure

Menopausal Status

Jane has been experiencing irregular menstrual cycles for the past year, with her last period occurring 8 months ago.

Blood tests show decreased estrogen levels, confirming she is in the menopausal transition phase.

Case Focus:

Angiotensinogen and Angiotensin Levels

Recent blood tests revealed elevated levels of angiotensinogen and increased activity of angiotensin II.

Jane’s hypertension, which was previously well-controlled, has shown a recent uptick, necessitating a review of her current hypertension management.

Impact on Menopausal Symptoms (Menopausal Transition)

The elevated angiotensin II could be contributing to the severity of Jane’s vasomotor symptoms, such as hot flashes and night sweats.

Her fluctuating blood pressure levels may be exacerbated by changes in the renin-angiotensin system due to menopause.

Treatment Plan

Jane’s healthcare provider suggests adjusting her hypertension medications, considering the use of ACE inhibitors that might also alleviate her menopausal symptoms.

Hormone Replacement Therapy (HRT) is discussed as an option to manage her menopausal symptoms, with consideration given to her family history and personal health risks.

Lifestyle modifications, including a balanced diet, regular exercise, and stress management techniques, are recommended to manage symptoms and overall health.

Follow-Up and Monitoring

Jane is scheduled for regular follow-up appointments to monitor her blood pressure, hormonal levels, and response to the treatment adjustments.Bone density tests are planned to assess her risk of osteoporosis, given her family history and menopausal status.


This case study of Jane Doe illustrates the complex interplay between the renin-angiotensin system and menopausal hormonal changes. It highlights the importance of a personalized approach in managing menopause, considering both hormonal fluctuations and other physiological changes, such as those in the RAS. Jane’s case underscores the need for comprehensive care and regular monitoring to manage menopause effectively and maintain overall health.


Leave a Reply

Your email address will not be published. Required fields are marked *

© 2023. All rights reserved.